Research Priorities

Bruneau’s lab research group studies the epidemiology of drug use and associated health problems, notably hepatitis C, chronic pain, and mental health. It also conducts intervention and program implementation studies using appropriate methodologies, including quantitative and qualitative methods and randomized trials.

Epidemiology of psychoactive substance use

Blood borne infections


Emerging issues

Implementation science

Youth and new users

Indigenous health

Mental health

Access to care


Dr. Julie Bruneau, MD, MSc


  • Canada Research Chair in addiction medicine
  • Professor in the Department of family medicine and emergency medicine, Université de Montréal
  • Head of the Department of General medicine at the CHUM
  • Co-founder of CHUM’s Addiction Medicine Unit
  • Co-author of several national guidelines for the management of opioid use disorders
  • Principal investigator of the Quebec-Atlantic Node of the Canadian Research Initiative in Substance Misuse (CRISM)


  • Dr. Bruneau advocates for safe access to health care for all;
  • She contributes to improving the understanding of factors impeding and facilitating harm reduction efforts to reduce HIV and HCV transmission among persons who inject drugs;
  • She conducts several large-scale clinical trials, implementation science and cohort studies to improve access, retention and quality care among persons who use drugs.

Start typing and press Enter to search